The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Regional variation limits applications of healthy gut microbiome reference ranges and disease models
Abstract
Dysbiosis, departure of the gut microbiome from a healthy state, has been suggested to be a powerful biomarker of disease incidence and progression 1-3. Diagnostic applications have been proposed for inflammatory bowel disease diagnosis and prognosis 4, colorectal cancer prescreening 5 and therapeutic choices in melanoma 6. Noninvasive sampling could facilitate large-scale public health applications, including early diagnosis and risk assessment in metabolic 7 and cardiovascular diseases 8. To understand the generalizability of microbiota-based diagnostic models of metabolic disease, we characterized the gut microbiota of 7,009 individuals from 14 districts within 1 province in China. Among phenotypes, host location showed the strongest associations with microbiota variations. Microbiota-based metabolic disease models developed in one location failed when used elsewhere, suggesting that such models cannot be extrapolated. Interpolated models performed much better, especially in diseases with obvious microbiota-related characteristics. Interpolation efficiency decreased as geographic scale increased, indicating a need to build localized baseline and disease models to predict metabolic risks.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Gut microbiome structures have been elucidated remarkably variable among different races and ethnicities.24”
From The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti–Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC (2019) · cites this paper as [24]
In the citing paper
“Even within a single continent, country-specific differences persist; ethnicity alone accounts for about 6% of interindividual variance, and migration studies show that acculturation rapidly shifts the microbiome toward the host country’s profile.69–72”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [71]
In the citing paper
“Geographical differences can also have a major role in human gut microbiota variation109 and have been shown to influence these GOMS40,110.”
From Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy (2023) · cites this paper as [109]
In the citing paper
“Like a report on districts in southern China56, we observed preponderances of distinct clusters at the US state level (four representative microbiotypes with uneven geographical distribution shown in Extended Data Fig. 10d), suggesting a possible explanation of inter-study differences.”
From Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1 (2022) · cites this paper as [56]
In the citing paper
“Multiple factors affect the composition of the human gut microbiome, including geography, diet, infection and drug usage56,61–64.”
From Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1 (2022) · cites this paper as [56]
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Self-citationSearch and clustering orders of magnitude faster than BLAST
Edgar, R. C. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq461 · Cited by 20,826
Human gut microbiome viewed across age and geography
Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M. G., Contreras, M., Magris, M., Hidalgo, G., Baldassano, R. N., Anokhin, A. P., et al. (2012) · Nature · doi:10.1038/nature11053 · Cited by 7,815
Self-citationGut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671
McDonald, D., Price, M. N., Goodrich, J., Nawrocki, E. P., DeSantis, T. Z., Probst, A., Andersen, G. L., Knight, R., & Hugenholtz, P. (2012) · The ISME Journal · doi:10.1038/ismej.2011.139 · Cited by 5,064
Self-citationThe Human Intestinal Microbiome in Health and Disease
Lynch, S. V., & Pedersen, O. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1600266 · Cited by 3,637
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109400 · Cited by 3,400
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
Morgan, X. C., Tickle, T. L., Sokol, H., Gevers, D., Devaney, K. L., Ward, D. V., Reyes, J. A., Shah, S. A., LeLeiko, N., Snapper, S. B., et al. (2012) · Genome Biology · doi:10.1186/gb-2012-13-9-r79 · Cited by 2,713
Current understanding of the human microbiome
Gilbert, J. A., Blaser, M. J., Caporaso, J. G., Jansson, J. K., Lynch, S. V., & Knight, R. (2018) · Nature Medicine · doi:10.1038/nm.4517 · Cited by 2,609
Self-citationPopulation-level analysis of gut microbiome variation
Falony, G., Joossens, M., Vieira-Silva, S., Wang, J., Darzi, Y., Faust, K., Kurilshikov, A., Bonder, M. J., Valles-Colomer, M., Vandeputte, D., et al. (2016) · Science · doi:10.1126/science.aad3503 · Cited by 2,400
Self-citation
Cited by
Role of gut microbiota in type 2 diabetes pathophysiology
Gurung, M., Li, Z., You, H., Rodrigues, R., Jump, D. B., Morgun, A., & Shulzhenko, N. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2019.11.051 · Cited by 1,708
“2018 [1], are concordant with the genus level analyses demonstrating positive associations between T2D and several OTUs of all three of these genera.”
BackgroundResultInfluentialGut microbiota in colorectal cancer: mechanisms of action and clinical applications
Wong, S. H., & Yu, J. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0209-8 · Cited by 1,331
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation
Peled, J. U., Gomes, A. L. C., Devlin, S. M., Littmann, E. R., Taur, Y., Sung, A. D., Weber, D., Hashimoto, D., Slingerland, A. E., Slingerland, J. B., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1900623 · Cited by 765
Improved metagenome binning and assembly using deep variational autoencoders
Nissen, J. N., Johansen, J., Allesøe, R. L., Sønderby, C. K., Armenteros, J. J. A., Grønbech, C. H., Jensen, L. J., Nielsen, H. B., Petersen, T. N., Winther, O., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-020-00777-4 · Cited by 649
Host variables confound gut microbiota studies of human disease
Vujkovic-Cvijin, I., Sklar, J., Jiang, L., Natarajan, L., Knight, R., & Belkaid, Y. (2020) · Nature · doi:10.1038/s41586-020-2881-9 · Cited by 614
Self-citation
Metadata
- Authors
- He, Y., Wu, W., Zheng, H.-M., Li, P., McDonald, D., Sheng, H.-F., Chen, M.-X., Chen, Z.-H., Ji, G.-Y., Zheng, Z.-D.-X., Mujagond, P., Chen, X.-J., Rong, Z.-H., Chen, P., Lyu, L.-Y., Wang, X., Wu, C.-B., Yu, N., Xu, Y.-J., Yin, J., Raes, J., Knight, R., Ma, W.-J., & Zhou, H.-W.
- Affiliations
- Zhujiang Hospital (CN)
- Guangdong Provincial Center for Disease Control and Prevention (CN)
- University of California San Diego (US)
- Regional Centre for Biotechnology (IN)
- Southern Medical University (CN)
- Nanfang Hospital (CN)
- Vrije Universiteit Brussel (BE)
- ORCID
- Venue
- Nature Medicine
- Published
- 2018-08-27
- Volume
- 24
- Issue
- 10
- Pages
- 1532-1535
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2887509155
- Semantic Scholar
- ddc3807a0e531fa226e337ed48feb8a3025516c1
- Cited by
- 894
- References
- 58
- Citations by year
- 2026: 55 · 2025: 83 · 2024: 138 · 2023: 102 · 2022: 143 · 2021: 149 · 2020: 143 · 2019: 71 · 2018: 8
- FWCI
- 35.13
- Type
- journal article
- Language
- en
- Update notices
- correction (2018-09-24)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Lirias (submittedVersion)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- gut microbiota, regional variation, metabolic disorders, model generalization, interpolation, dysbiosis, non-invasive biomarkers
- MeSH terms
- Gastrointestinal Microbiome, China, Female, Humans, Male, Metabolic Diseases, Prognosis, Host-Pathogen Interactions, Phylogeography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Regional variation limits applications of healthy gut microbiome reference ranges and disease models. https://app.cochat.ai/papers/10.1038/s41591-018-0164-x
- The paper
- He, Y., Wu, W., Zheng, H.-M., Li, P., McDonald, D., Sheng, H.-F., Chen, M.-X., Chen, Z.-H., Ji, G.-Y., Zheng, Z.-D.-X., Mujagond, P., Chen, X.-J., Rong, Z.-H., Chen, P., Lyu, L.-Y., Wang, X., Wu, C.-B., Yu, N., Xu, Y.-J., . . . Zhou, H.-W. (2018). Regional variation limits applications of healthy gut microbiome reference ranges and disease models. Nature Medicine. https://doi.org/10.1038/s41591-018-0164-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.